GlassScriptPhysician profile
Nathan C Page
NPI 1306994595
$3,104.31
in general payments reported to CMS, 2019-2025
8 companies · $2,243 in 2025
The $2,243 reported for 2025 was more than what 91% of Pediatric Otolaryngology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2021: $13.88 · 2022: $319 · 2024: $298 · 2025: $2,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,052 · Food and Beverage: $489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,052.00 |
| Food and Beverage | $488.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | $2,186.68 | 2025 | |
| Preceptis Medical, INC. | $411.65 | 2022-2025 | Hummingbird Tympanostomy Tube System |
| Cochlear Americas | $262.84 | 2019-2022 | |
| Integra Lifesciences Corporation | $118.75 | 2024 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Med-El Corporation | $74.30 | 2019 | |
| Acclarent, INC | $22.19 | 2019 | |
| Medtronic USA, INC. | $16.90 | 2019 | |
| Stryker Corporation | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Page listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.